Department of Pathology and Laboratory Medicine, School of Medicine and Public Health, University of Wisconsin, 1300 University Avenue, Madison, WI 53706, USA.
J Neuroimmune Pharmacol. 2010 Jun;5(2):210-9. doi: 10.1007/s11481-010-9199-6. Epub 2010 Mar 24.
Mycobacterial suppression of central nervous system (CNS) autoimmunity has been demonstrated in various experimental models, epidemiological studies, and clinical trials. Recent studies have led to an increased understanding of the cellular and molecular interactions involved in the pathogenesis of autoimmune diseases and of mycobacterial immunity. Here, we review some of the mechanisms by which mycobacterial infection might modulate the clinical course of CNS autoimmunity. A more complete understanding of these mechanisms may lead to the development of novel immunotherapeutic tools for treating autoimmune diseases.
分枝杆菌对中枢神经系统(CNS)自身免疫的抑制作用已在各种实验模型、流行病学研究和临床试验中得到证实。最近的研究加深了人们对参与自身免疫性疾病发病机制和分枝杆菌免疫的细胞和分子相互作用的理解。在这里,我们回顾了分枝杆菌感染可能调节 CNS 自身免疫临床病程的一些机制。对这些机制的更全面了解可能会导致开发出治疗自身免疫性疾病的新型免疫治疗工具。